Haridarshan Patel

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Patient Reported Outcomes

Top Venues

International journal of colorectal disease

Pharmacotherapy

Inflammatory bowel diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Burisch J, Ailsa L Hart, Andreas Sturm, Christine Rudolph, Rachael Meadows, Anna Jus, Fatima Dawod, Haridarshan Patel, Alessandro Armuzzi
Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey. Inflammatory bowel diseases (2024)
Bernd Bokemeyer, Nils Picker, Daniel Kromer, Ludger Rosin, Haridarshan Patel
Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in Germany. International journal of colorectal disease 38 (1) (2023)
Bernd Bokemeyer, Nils Picker, Daniel Kromer, Ludger Rosin, Haridarshan Patel
Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in Germany. International journal of colorectal disease 38 (1) (2023)
Bernd Bokemeyer, Nils Picker, Daniel Kromer, Ludger Rosin, Haridarshan Patel
Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in Germany. International journal of colorectal disease 38 (1) (2023)
James O Lindsay, Nils Picker, Daniel Kromer, Michael Smyth, Haridarshan Patel
The incidence of remission and indicators of inadequate response to advanced therapy in patients with ulcerative colitis: results from medical charts in the United Kingdom. Current medical research and opinion (2023)
Haridarshan Patel, Robert J DiDomenico, Katie J Suda, Glen T Schumock, Gregory S Calip, Todd A Lee
Risk of cardiac events with azithromycin-A prediction model. PloS one 15 (10) (2020)
Haridarshan Patel, Gregory Sampang Calip, Robert J DiDomenico, Glen T Schumock, Katie J Suda, Todd A Lee
Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms. Pharmacotherapy 40 (2) (2020)